Bath & Body Works has updated its 2026 financial guidance, narrowing its projected sales decline and raising its full-year EPS outlook. This mixed guidance, with a positive adjustment to EPS but still a projected sales decline, suggests a focus on profitability amidst ongoing revenue challenges.
Bath & Body Works (BBWI) has provided an updated financial outlook for fiscal year 2026 and Q3 2026. The company narrowed its full-year 2026 net sales decline projection, which is a slight improvement, but still indicates a contraction. More positively, it raised its full-year 2026 earnings per diluted share (EPS) guidance, suggesting improved profitability or cost management. However, the adjusted EPS guidance for 2026 is still lower than 2025, and Q3 2026 sales and EPS are projected to decline significantly year-over-year. This mixed bag of guidance presents a neutral to slightly positive short-term outlook for traders, as the raised EPS could offset some concerns about declining sales, but the overall trend remains challenging. The generation of $650 million in free cash flow is a positive for liquidity and potential shareholder returns, but the lack of share repurchases in the outlook might temper enthusiasm.